Phaarmasia Ltd.

View in App
26.99 +1.04 ▲4.0%

29 September 2023, 04:01:00 PM
Volume: 1,069

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.phaarmasia.in
Market Cap 18.43 Cr.
Enterprise Value(EV) 17.74 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -1.82 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-06
Industry PE 38.47 Trailing Twelve Months Ending 2023-06
Book Value / Share 9.23 Trailing Twelve Months Ending 2023-06
Price to Book Value 2.92 Calculated using Price: 26.99
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.68 Cr. 6,826,960 Shares
FaceValue 10
About Phaarmasia Ltd.
The company was incorporated on February 6,1981 as Phaarmasia Private Limited, and the company was converted into a public limited company, Phaarmasia Limited on February 15, 1992, it is into manufacturing of pharmaceutical formulations. Company's facilities are spread over in 3 acres of land with built up area of 90,000 sq.ft.

Phaarmasia Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Phaarmasia Ltd. Performance

View details >>
1 Day
+4.01%
1 Week
+1.50%
1 Month
+7.27%
3 Month
+12.69%
6 Month
+10.98%
1 Year
+6.05%
2 Year
+3.21%
5 Year
+25.83%
10 Year
+114.21%

Phaarmasia Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.86 0.55 2.16 7.54 9.51 6.08 3.36 -17.96 -17.50
Return on Capital Employed (%) 5.28 3.35 3.63 9.32 10.35 11.07 5.24 -18.00 -19.24
Return on Assets (%) 0.86 0.22 0.85 2.76 2.82 1.61 1.12 -7.18 -5.08

Phaarmasia Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 7 13 12 12 12 13 13 14 12 11
Non Curr. Liab. 0 0 0 1 1 1 1 0 0 0
Curr. Liab. 6 6 6 7 9 20 19 8 9 17
Minority Int.
Equity & Liab. 13 19 19 20 22 33 34 22 21 28
Non Curr. Assets 11 16 14 14 14 14 14 13 13 13
Curr. Assets 3 3 4 6 8 19 20 9 8 15
Misc. Exp. not W/O
Total Assets 13 19 19 20 22 33 34 22 21 28

Phaarmasia Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 19 22 14 20 24 24 20 17 27 29
Other Income 0 1 1 1 1 1 1 0 1 1
Total Income 19 22 15 21 25 25 21 18 28 30
Total Expenditure -18 -21 -14 -20 -23 -24 -20 -19 -29 -31
PBIDT 1 1 1 1 1 1 1 -1 -1 -1
Interest 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 1 1 1 0 -2 -1 -1
Adjusted EPS 0 0 0 1 1 1 0 -2 -2 -2

Phaarmasia Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 1 0 0 0 0 1
Cash Fr. Inv. 0 0 0 0 -1 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 1

Phaarmasia Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 73.51 73.51 73.51 73.51 73.51 73.51 73.51 73.51 73.51
Public 26.49 26.49 26.49 26.49 26.49 26.49 26.49 26.49 26.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Phaarmasia Ltd. Announcements

View details >>
Sat, 30 Sep 2023
Closure of Trading Window
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with SEBI (PIT) Reg 2015 The Company has intimated to all its Directors Key Managerial Personnel and Designated Employees regarding the closure of the trading window of the Company from 01st of October 2023 till 48 hours from the conclusion of the Board meeting in which the audited financial results for the quarter ended of the quarter ended 30th September 2023
Thu, 31 Aug 2023
Compliances-Reg. 39 (3) - Details Of Loss Of Certificate / Duplicate Certificate
Intimation Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015
Thu, 17 Aug 2023
Newspaper Advertisement Of Unaudited Financial Results Quarter Ended 30Th June 2023
Newspaper Advertisement for the Quarter ended 30th June 2023

Phaarmasia Ltd. Technical Scans

View details >>
Fri, 29 Sep 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month High Close Crossing Last Month High
Opening at High Opening at High

Phaarmasia Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 278,106.92 1,159.10 +2.4%
Divi's Laboratories Ltd. 99,942.28 3,761.95 +2.7%
Cipla Ltd. 95,813.38 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. 93,178.48 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. 73,867.93 5,149.95 +2.5%
Mankind Pharma Ltd. 71,831.52 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. 65,264.13 1,928.35 +3.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.97 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.60 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 30.87 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.76 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.76 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 56.04 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 51.80 1,928.35 +3.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.79 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.61 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 3.95 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.80 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.81 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.87 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.92 1,928.35 +3.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,928.35 +3.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,928.35 +3.4%

Phaarmasia Ltd. FAQ's

What is Phaarmasia share price?
Can I buy Phaarmasia shares now?
What is the Market Cap of Phaarmasia?
What are the key metrics to analyse Phaarmasia?
What is the 52 Week High and Low of Phaarmasia?
What is the trend of Phaarmasia share price?